Cytosorbents
CTSO
#10826
Rank
โ‚ฌ13.92 M
Marketcap
4,42ย โ‚ฌ
Share price
-9.31%
Change (1 day)
678.71%
Change (1 year)

EPS for Cytosorbents (CTSO)

EPS in 2026 (TTM): -4,99ย โ‚ฌ

According to Cytosorbents's latest financial reports the company's current EPS (TTM) is -5,26ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,36ย โ‚ฌ an increase over its 2024 EPS that were of -6,71ย โ‚ฌ.

EPS history for Cytosorbents from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,99ย โ‚ฌ111.58%
2025-2,36ย โ‚ฌ-64.85%
2024-6,71ย โ‚ฌ
2021-10,30ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Boston Scientific
BSX
2,15ย โ‚ฌ-140.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
2,21ย โ‚ฌ-141.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
0,88ย โ‚ฌ-116.72%๐Ÿ‡บ๐Ÿ‡ธ USA